Literature DB >> 2940116

Atrial natriuretic factor: an overview.

A J de Bold.   

Abstract

Heart atrial muscle cells in mammals are differentiated for a contractile as well as a secretory function. Through the latter, the heart plays an endocrine role; it synthesizes, stores, and releases a group of peptides collectively referred to as atrial natriuretic factor (ANF). ANF has natriuretic and hypotensive properties as well as an inhibitory effect on aldosterone and renin secretion. Thus ANF intervenes in the short- and long-term regulation of water and electrolyte balance and blood pressure. It is expected that further research in this new field will provide fresh insights into the pathophysiology of several important clinical entities and in the development of new pharmaceutical products.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2940116

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  8 in total

Review 1.  Evolution of the membrane guanylate cyclase transduction system.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Membrane guanylate cyclase is a beautiful signal transduction machine: overview.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-03       Impact factor: 3.396

3.  Influence of sodium balance on atrial natriuretic factor in rats with one-kidney, one-clip renal hypertension.

Authors:  A L Lattion; J P Flückiger; B Waeber; J Nussberger; J F Aubert; H R Brunner
Journal:  Experientia       Date:  1990-01-15

4.  Cardiac atria are the primary source of ANP release in hypoxia-adapted rats.

Authors:  Brian Casserly; Linda Pietras; Joy Schuyler; Richard Wang; Nicholas S Hill; James R Klinger
Journal:  Life Sci       Date:  2010-08-05       Impact factor: 5.037

5.  Atrial natriuretic peptides elevate cyclic GMP levels in primary cultures of rat ependymal cells.

Authors:  John Wellard; Mirna Rapp; Bernd Hamprecht; Stephan Verleysdonk
Journal:  Neurochem Res       Date:  2003-02       Impact factor: 3.996

6.  Plasma atrial natriuretic factor levels in the inferior petrosal sinus blood of patients with Cushing's disease before and after corticotropin-releasing hormone administration.

Authors:  A Colao; R Pivonello; D Ferone; G La Tessa; A Faggiano; G Facciolli; C Di Somma; B Merola; G Lombardi
Journal:  J Endocrinol Invest       Date:  1998-04       Impact factor: 4.256

7.  Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.

Authors:  M A Lee; R E West; J Moss
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

8.  Effect of atrial natriuretic factor on permeability of the blood-cerebrospinal fluid barrier.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.